Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Alcohol Use Disorder in Cirrhotics
NCT06496191Recruiting
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jul 2024
- Primary completion
- Jun 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, open-label trial in alcohol use disorder (AUD) comparing FMT + SMT with Placebo + SMT (2 arms). Primary endpoint: Proportion of patients achieving and maintaining alcohol abstinence at 4 weeks. Started Jul 2024; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06496191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06496191.